Schizophrenia market to reach $17 billion in 7MM by 2031, forecasts GlobalData
Pipeline innovations set to drive schizophrenia market growth despite generic competition
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Unmet needs in chronic hand eczema present clear demand for new treatments: GlobalData
Innovative therapies targeting inflammation offer hope for improved chronic hand eczema care
Gerresheimer: FDA grants tentative approval of SQ innovation’s Lasix ONYU
Patented device technology for precise administration
Biocon Biologics’ Ustekinumab Biosimilar receives positive CHMP opinion
YESINTEK recommended for approval to treat psoriasis, psoriatic arthritis, and Crohn’s disease in adults and children
Anil Matai reflects on 2024 as a pivotal year for India’s pharma sector
OPPI DG highlights government initiatives and industry efforts shaping a patient-centric, innovation-driven future
Lupin acquires anti-diabetes trademarks from Boehringer Ingelheim to strengthen portfolio
Lupin expands its diabetes portfolio with the acquisition of GIBTULIO, GIBTULIO MET, and AJADUO trademarks
Glenmark launches Lacosamide Oral Solution, bioequivalent to Vimpat
Lacosamide Oral Solution, 10 mg/mL, enters the U.S. market with an annual market size of $57 million
Rusan Pharma achieves key GMP approvals for Australian and Brazilian markets
Rusan Pharma expands its global footprint with TGA and ANVISA GMP certifications for its transdermal patch and oral film…
Kiran Mazumdar-Shaw receives 2024 Jamsetji Tata Award
Biocon Chairperson honoured by ISQ for leadership in quality and global contributions to the biosciences sector
AIPAC launches inaugural programme for MSMEs in pharma sector
Event focuses on skill development and scientific excellence for MSMEs, with participation from industry experts, academia, and…
From pills to pollution: Need for eco-pharmacovigilance to safeguard environmental sustainability
John Praveen, Associate VP - Pharmacovigilance and Medical Writing Portfolio Delivery Lead & PV/MW Shared Services Offering…
Pharmaceutical data and analytics market to grow to $2.1 bn by 2028: GlobalData
China represents the largest market for data and analytics in the pharmaceutical sector, contributing roughly 20.2 per cent of…
Dr Jitendra Singh chairs the 2nd Annual General Meeting of Biotechnology Research and Innovation…
During the meeting, Dr Singh announced the successful gene therapy trial for Haemophilia conducted with the support of the…
East Ocyon Bio closes $4.2M Seed round led by Aeravti Ventures and Micro Labs
The funds raised will be utilised to enable several key initiatives like pre-clinical testing of CAR-NK and CAR-gamma delta T cell…
Govt agencies, non-govt organisations collaborate on non-animal methodologies workshop
Biotechnology Industry Research Assistance Council, Office of Principal Scientific Advisor and Humane Society International/India…
Power Gummies raises ₹10 cr, aims to expand product range
The funding would be used to launch a zero-sugar range, upgrade compositions to make the brand sugar-free and diversify into…
SKAN Research Trust secures two govt recognitions
The recognitions include Research Association for Scientific Research under Section 35(1)(ii) of the Income-tax Act, 1961 and…
Asahi Kasei Pharma enters into exclusive license agreement for anti-CX3CR1 Antibody
The anti-CX3CR1 antibody, currently in preclinical development, works by inhibiting CX3CR1, a receptor involved in immune cell…
Gerresheimer completes acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma…
The acquisition creates a new moulded glass unit with a diversified product portfolio for the pharmaceutical, cosmetics, food and…
Toripalimab can fortify Dr. Reddy’s oncology portfolio as first checkpoint inhibitor for NPC in…
Dr. Reddy's Laboratories, in collaboration with Shanghai Junshi Biosciences has recently launched checkpoint inhibitor Zytorvi…